兰州大学机构库

Browse/Search Results:  1-10 of 241 Help

Selected(0)Clear Items/Page:    Sort:
Deriving Immune Modulating Drugs from Viruses-A New Class of Biologics 期刊论文
JOURNAL OF CLINICAL MEDICINE, 2020, 卷号: 9, 期号: 4
Authors:  Yaron, Jordan R.;  Zhang, Liqiang;  Guo, Qiuyun;  Burgin, Michelle;  Schutz, Lauren N.;  Awo, Enkidia;  Wise, Lyn;  Krause, Kurt L.;  Ildefonso, Cristhian J.;  Kwiecien, Jacek M....Yaron, Jordan R.;  Zhang, Liqiang;  Guo, Qiuyun;  Burgin, Michelle;  Schutz, Lauren N.;  Awo, Enkidia;  Wise, Lyn;  Krause, Kurt L.;  Ildefonso, Cristhian J.;  Kwiecien, Jacek M.;  Juby, Michael;  Rahman, Masmudur M.;  Chen, Hao;  Moyer, Richard W.;  Alcami, Antonio;  McFadden, Grant;  Lucas, Alexandra R.
Adobe PDF(2575Kb)  |  Favorite  |    Submit date:2020/07/13
virus  immune modulation  protein  serpin  chemokine binding protein  chemokine  growth factor  cytokine  interleukin  therapeutic  biologic  
A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology 期刊论文
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2020, 卷号: 20, 期号: 1
Authors:  Zhang, Jingyuan;  Liu, Xinkui;  Wu, Jiarui;  Zhou, Wei;  Tian, Jinhui;  Guo, Siyu;  Jia, Shan Shan;  Meng, Ziqi;  Ni, Mengwei
Adobe PDF(5668Kb)  |  Favorite  |    Submit date:2020/12/18
Yinchenhao decoction  Hepatitis C  Network pharmacology  Bioinformatics  
Respiratory rhythmogenesis in healthy humans and patients with chronic obstructive pulmonary disease: a theoretical approach 期刊论文
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 卷号: 27, 页码: 85-85
Authors:  Yu, L;  De Mazancourt, M;  Berthault, A;  Clerici, C;  Courbage, M;  Mangin, L
Adobe PDF(1269Kb)  |  Favorite  |    Submit date:2015/05/25
respiratory neural network-mathematical model-COPD  
Dynamics of the voluntary respiratory neural network in chronic obstructive pulmonary disease assess with cerebral functional magnetic resonance imaging 期刊论文
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 卷号: 27, 页码: 85-85
Authors:  Hess, A;  Yu, L;  Klein, I;  De Mazancourt, M;  Jebrak, G;  Mal, H;  Fournier, M;  Schouman-Clayes, E;  Courbage, M;  Clerici, C...Hess, A;  Yu, L;  Klein, I;  De Mazancourt, M;  Jebrak, G;  Mal, H;  Fournier, M;  Schouman-Clayes, E;  Courbage, M;  Clerici, C;  Mangin, L
Adobe PDF(1269Kb)  |  Favorite  |    Submit date:2015/05/25
respiratory neural network-fMRI-COPD  
Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: A computational study 期刊论文
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 卷号: 1820, 期号: 10, 页码: 1526-1534
Authors:  Pan, DB;  Xue, WW;  Zhang, WQ;  Liu, HX(刘焕香);  Yao, XJ(姚小军);  Liu, HX (reprint author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.
Adobe PDF(1800Kb)  |  Favorite  |    Submit date:2015/12/29
Hepatitis C virus  NS3/4A protease  Drug resistance  ITMN-191  Molecular dynamics simulation  
Rapid detection of hepatitis C virus RNA by a reverse transcription loop-mediated isothermal amplification assay 期刊论文
FEMS IMMUNOL MED MIC, 2011, 卷号: 63, 期号: 1, 页码: 144-147
Authors:  Wang, QQ;  Zhang, J;  Hu, JS;  Chen, HT;  Du, L;  Wu, LQ;  Ding, YZ;  Xiong, SH;  Huang, XC;  Zhang, YH...Wang, QQ;  Zhang, J;  Hu, JS;  Chen, HT;  Du, L;  Wu, LQ;  Ding, YZ;  Xiong, SH;  Huang, XC;  Zhang, YH;  Liu, YS;  Liu, YS (reprint author), CAAS, LVRI, State Key Lab Vet Etiol Biol, Xujiaping 1, Lanzhou 730046, Gansu, Peoples R China.
Adobe PDF(228Kb)  |  Favorite  |    Submit date:2015/12/23
hepatitis C virus  reverse transcription loop-mediated isothermal amplification  sensitivity  specificity  
Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598 期刊论文
ANTIVIRAL RESEARCH, 2014, 卷号: 104
Authors:  Xue, WW;  Jiao, PZ;  Liu, HX;  Yao, XJ(姚小军);  Yao, XJ (reprint author), Lanzhou Univ, State Key Lab Appl Organ Chem, Dept Chem, Lanzhou 730000, Peoples R China.
Adobe PDF(3600Kb)  |  Favorite  |    Submit date:2014/12/05
HCV NS5B polymerase  Mutation-induced drug resistance  Molecular docking  MD simulation  Binding free energy calculation  Residue interaction network  
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B 期刊论文
Journal of Clinical and Translational Hepatology, 2019, 卷号: 7, 期号: 4, 页码: 322-328
Authors:  Shan, Shan;  You, Hong;  Niu, Junqi;  Shang, Jia;  Xie, Wen;  Zhang, Yuexin;  Li, Xun;  Ren, Hong;  Tang, Hong;  Ding, Huiguo...Shan, Shan;  You, Hong;  Niu, Junqi;  Shang, Jia;  Xie, Wen;  Zhang, Yuexin;  Li, Xun;  Ren, Hong;  Tang, Hong;  Ding, Huiguo;  Wang, Xihong;  Nan, Yuemin;  Dou, Xiaoguang;  Han, Tao;  Zhang, Lingyi;  Liu, Xiaoqing;  Deng, Cunliang;  Cheng, Jilin;  Wang, Xiaozhong;  Xie, Qing;  Lin, Shumei;  Huang, Yan;  Xu, Youqing;  Xiong, Yong;  Li, Wu;  Yan, Xuebing;  Piao, Hongxin;  Huang, Wenxiang;  Lu, Qinghua;  Gong, Weijin;  Li, Shiping;  Hu, Xiaoxuan;  Zhang, Xiaolan;  Liu, Shourong;  Li, Yufang;  Yang, Dongliang;  Li, Hai;  Yang, Caixia;  Cheng, Mingliang;  Zhang, Liaoyun;  Zheng, Huanwei;  Luo, Xinhua;  Lin, Feng;  Wang, Lei;  Xu, Guanghua;  Xu, Xiaoyuan;  Wei, Lai;  Hou, Jinlin;  Duan, Zhongping;  Zhuang, Hui;  Yang, Xizhong;  Kong, Yuanyuan;  Jia, Jidong
Adobe PDF(471Kb)  |  Favorite  |    Submit date:2020/08/29
Hepatitis B  Treatment  Registry  
Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis 期刊论文
Hepatology International, 2020, 卷号: 14, 期号: 2, 页码: 180-189
Authors:  Wu, Yuchao;  Liu, Jinfeng;  Feng, Yali;  Fu, Shan;  Ji, Fanpu;  Ge, Long;  Yao, Naijuan;  Luo, Xufei;  Zhao, Yingren;  Chen, Yaolong...Wu, Yuchao;  Liu, Jinfeng;  Feng, Yali;  Fu, Shan;  Ji, Fanpu;  Ge, Long;  Yao, Naijuan;  Luo, Xufei;  Zhao, Yingren;  Chen, Yaolong;  Yang, Yuan;  Chen, Tianyan
Adobe PDF(1887Kb)  |  Favorite  |    Submit date:2020/08/06
Hepatitis B  Mother-to-child transmission  Pregnancy  Antiviral treatment  Network meta-analysis  Lamivudine  Telbivudine  Tenofovir  Efficacy  Safety outcomes  
Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis 期刊论文
Journal of Clinical and Translational Hepatology, 2020, 卷号: 8, 期号: 3, 页码: 255-261
Authors:  Rao, Huiying;  Yang, Xingxiang;  Tan, Youwen;  Ning, Qin;  Yang, Daokun;  Wang, Jiefei;  Yang, Yongfeng;  Zheng, Sujun;  Yang, Dongliang;  Hou, Jinlin...Rao, Huiying;  Yang, Xingxiang;  Tan, Youwen;  Ning, Qin;  Yang, Daokun;  Wang, Jiefei;  Yang, Yongfeng;  Zheng, Sujun;  Yang, Dongliang;  Hou, Jinlin;  Xie, Qing;  Zhao, Caiyan;  Zhang, Lunli;  Mao, Xiaorong;  Sun, Tong;  Bai, Lang;  Zhang, Fuchun;  Jin, Jinglan;  Zhao, Yingren;  Wang, Maorong;  Xie, Wen;  Ma, Yingjie;  Quan, Jun;  Yan, Xuebing;  An, Ping;  Lin, Feng;  Jia, Jidong;  Hu, Xiaoxuan;  Gong, Zuojiong;  Wu, Jie;  Chen, Yongping;  Jia, Zhansheng;  Lin, Minghua;  Wang, Guiqiang;  Zhu, Yueyong;  Zhang, Yingjun;  Xie, Hongming;  Luo, Lin;  Ren, Qingyun;  Huang, Rui;  Wei, Lai
Adobe PDF(3163Kb)  |  Favorite  |    Submit date:2020/12/17
Hepatitis C virus  Genotype 1  Direct acting antivirals  Emitasvir  Sofosbuvir  Combination treatment